Renal Cancer also known as Renal cell adenocarcinoma (RCC) or Kidney cancer are a group of cancers that start from the kidneys. Symptoms of renal cancer can include lumps in the abdomen, blood in the urine, or chronic back pain. Other symptoms can include rapid weight loss, fever. Kidney cancer is diagnosed with oncologists find abnormal growth of cells in the kidney tissue. Over time, these cells form a tissue mass known as a tumor.
Kidney cancer can begin when something in the environment triggers a change in renal cells causing them to divide uncontrollably. If a malignant or cancerous tumor can spreads to other tissues or vital organs it’s called metastasis. Kidney cancer can metastasize to several organs including the liver, lungs or brain.
Global Kidney Cancer Statistics
Based on recent statistics from 2021, Renal cancer is the ninth most commonly occurring cancer in men and the fourteenth-most common cancer type in women. The total number of patients with renal cell adenocarcinoma cancer has nearly tripled since the 1980s. There is an increasing global trend for the incidence of kidney cancer globally, particularly in younger populations and european countries. Doctors have identified several modifiable risk factors for developing kidney cancer. The rapicly increasing incidence of kidney cancer amongst young individuals is quite worrying and requires early intervention with active preventive measures.
Those most susceptible to developing kidney cancer include: People between the ages of 65 and 74 have the highest incidence of developing kidney cancer, and the prevalence of the condition in men is two times that in women. Additionally, Native Americans and people of African descent are disproportionately affected. In contrast to adults, children seldom get kidney cancer. However, every year, between 5000 and 6000 children are diagnosed with Wilms tumours, a rare kind of kidney cancer.
Types of Kidney Cancer
There are many kidney cancer variations and each type is quite different in the way it develops and mutates over time. Treatment options also vary depending on the type, scale, and severity of the diagnosis. The three most common types of renal cancer include:
Renal cell carcinoma (RCC)
RCC is the most common form of kidney cancer in the world. RCC is responsible for 85% of all kidney malignancies and is the most frequent kind of kidney cancer in adults. While renal cell carcinoma most often manifests as a solitary tumor in just one kidney, it can also spread to the other organs and often seen in patients with chronic liver disease and alcoholic liver cirrhosis. Cancer develops in the tubular epithelium that lines your kidneys (tiny tubes that return nutrients and fluid to your blood). Clear-cell renal cell carcinoma (RCC) accounts for most cases (ccRCC).
Transitional cell carcinomas
Six to seven per cent of all kidney malignancies are transitional cell carcinomas. Uterine carcinoma typically develops at the point where the ureter branches off from the kidney proper. Your renal pelvis is the place where your kidneys are located. The ureters and bladder are potentially potential sites of progression for transitional cell cancer. 
Renal sarcoma is extremely rare, making up about 1% of all instances of kidney cancer. The kidneys are the site of origin for this disease, which can spread to other organs and bones if left untreated. Renal sarcoma forms in oft tissue, the connective tissue surrounding the kidneys or the adipose fat around the kidneys. Less than 1 percent of identified kidney cancers are classified as renal sarcoma.
Wilms tumour is commonly a type of renal cancer in children. Wilms’ tumor is also known as nephroblastoma, and most often affects children from the ages 3 to 5 but becomes much less previlent after the age of 5.
How Common is Renal cancer?
About 9.7% of all malignancies are diagnosed as kidney cancer. On average, around 566,000 people are diagnosed with kidney cancer each year, and renal cancer is more likely to be diagnosed in older people. In its early stages, kidney cancer may not cause any symptoms. Yet, signs and symptoms may emerge as the tumor develops. This is why kidney cancer is frequently not identified until it has already spread to other organs.
Metastatic renal cancer – Secondary kidney cancer
When cancer is found in the kidney, it might not have developed there but has metastasized (spread) from bone cancer or other organs, resulting in prostate cancer, colon cancer, lung cancer, pancreas cancer, stomach, prostate cancer or breast cancer. Since this type of cancer has spread from another (primary) site, it is referred to as secondary renal cancer. These naming and treatment options for the tumors are based on the original primary site where it started. For example, cancer that started in the pancreas and spread to the kidney is referred to as pancreatic cancer, and not kidney cancer. It is also treated like pancreatic cancer. In North America & Europe, secondary (metastatic) renal tumors are more commonly diagnosed than primary kidney cancer, but the opposite is true for many parts of Asia (Thailand), South America and Africa.
Benign Kidney Tumors
Sometimes, the tumors found in the Kidneys are classified as noncancerous (benign). This type of cancer usually doesn’t cause any severe symptoms or discomfort. Benign renal tumors are often found by chance when a patient undergoes imaging tests for other health conditions. Common benign tumors in the kidneys include:
- Renal adenoma – Adenoma on the kidneys are one of the most common benign kidney tumors. They are usually small and low-grade growths.
- Renal oncocytomas – Oncocytomas are also benign (asymptomatic) tumors that can grow large. These tumors can develop throughout the body and not unique to kidney tissue.
- Cysts and polycystic kidney disease
- Fibroma – Fibromas are also tumors on fibrous tissue surrounding the kidneys. This type of cancer is very rare and more common in women.
- Lipoma – Lipomas are renal tumors that originate in the fat cells in the renal capsule or surrounding tissue. Lipomas usually occur in middle-aged women.
- Angiomyolipoma are also known as angiomyolipomas or renal hematoma and are typically benign tumors caused by an familial genetic mutations. This diagnosis can be isolated but often associated with the genetic disease known as tuberous sclerosis. Patients with tuberous sclerosis can get tumors in the prostate, skin, liver cancer, brain, colorectal cancer and other vital systems.
Symptoms of kidney cancer
- Uterine bleeding (hematuria)
- You have a mass near one of your kidneys
- Experiencing aches in the flank
- Frequent tiredness or brain fog
- A pervasive malaise; an absence of health
- Disturbance in normal eating habits.
- Rapid weight loss
- A persistent mild fever
- Abnormally high blood pressure
- Significant amounts of calcium
The Four Stages of Kidney Cancer
An important part of dealing with kidney cancer is by first classifying it into one of fours stages it is currently in. This helps with planning for the appropriate treatment based on stage and severity. The stage of renal cancer will be based on several factors including staging & diagnostic to accurately determine which stage kidney cancer is in.
There are essentially four basic stages:
- Stage 1 kidney cancer: Cancer has not spread to any other organs is localized in the kidneys and is smaller than 7 cm in diameter
- Stage 2 kidney cancer: Cancer has not spread to any other organs is localized in the kidneys but is larger than 7 cm in diameter
- Stage 3 kidney cancer: Cancer might be any size and has spread to nearby organs outside of the kidneys
- Stage 4 kidney cancer: Cancer has spread from the kidneys and metastasized to distant locations including lungs, lymph nodes, brain, bones and liver.
What Are Lymph nodes?
Lymph nodes are like little “filters,” collecting and storing white blood cells that may be used to fend against infections. To measure the level of dysfunction in am patients lymph nodes and to measure the size of tumors, a doctor utilizes radiology scans such as CT and MRI, along with biological samples (via biopsy) from tumours, to establish the extent of the disease.
Grades are assigned to tumours to reflect the degree to which their cells deviate from normality. The rate of tumour growth can also be estimated by grading. High-grade tumors are characterized by rapidly dividing abnormal cells that don’t resemble healthy tissue. It is common for high-grade tumors to develop and spread faster than low-grade ones.
Diagnostic tests for kidney cancer
To reach a diagnosis, an oncologist looks thorough a patients medical history records and do a preliminary physical examination looking for signs of kidney cancer. They may also request tests that aid in detecting and evaluating cancer. Indicators that may be used in such examinations are:
- Urinalysis – Urine samples are used to check for the presence of blood. Urine tests can identify even the tiniest amounts of blood that would be undetectable to the human eye.
- Blood tests are used for checking your electrolyte levels and counting your blood cell types. Reduced red blood cell count (anaemia) and renal disease are detectable with a simple blood test (by looking at the creatinine levels).
- A computed tomography (CT) scan is an X-ray that employs a computer to produce several cross-sectional pictures of the body. Intravenous contrast is commonly used in this examination (dye), and Dye administration may be unsafe for those with compromised renal function.
- Cystoscopy scans allow doctors to see inside the patients body via a very thin, flexible tube known as a cystoscope
- A powerful radiomagnet is used in an MRI scan to create pictures of the organs and structures deep within the human body.
- An ultrasound scan can be used to examine the body to produce pictures on a screen by sending high-frequency sound waves into the tissues. Tumors have a different density than healthy tissues; thus, this test can assist in finding them.
- A renal mass biopsy entails inserting a tiny needle into the tumour and removing a tissue sample (biopsy). A pathologist can examine the sample tissue under a microscope to determine whether or not cancer cells are present. Your doctor may or may not prescribe a kidney biopsy because of the test’s limited accuracy in detecting cancer.
- Renal Arteriogram. This test is used to evaluate the blood supply to the tumour. It is not given often, but may help diagnose small tumors. It has other uses, as well. 
Kidney Cancer Prevention & Risk Factors
Major risk factors associated with cancer in the kidneys include:
- History of acute renal injury or kidney disease
- Family history of kidney cancer. This risk is very high in siblings
- Smoking tobacco
- Alcohol abuse
- History of High Bloodpressure
- Being on long-term dialysis
- Exposure to environmental toxins or chemicals such as cadmium, asbestos, organic solvents, benzene and some broad spectrum herbicides.
Having any of some of these risk factors does not mean you will automatically get kidney cancer. It’s also possible that patients can have none of these symptoms but still get the disease.
TREATMENT PRECAUTIONS & RISKSPlease Note That Not All Patients Qualify for Kidney Cancer treatment via Immunotherapy or Enriched NK Cells. Patients with late stage, severe underlying conditions or travel restrictions will not be eligible for the estimated 2-3 week treatment protocol.
Treatment Options for Kidney Cancer
When a patient is diagnosed with kidney cancer, oncologists will first try to determine if the cancer tumors have spread, and if so, how far. Oncologists can then use the patient’s cancer stage and current health to discuss best treatment options that offer the highest survival chances.
Surgery for Kidney Cancer & Kidney Tumors
Surgery is still considered the first option for treatment for benign kidney tumors or non-metastasized kidney cancer. Laparoscopic surgeries offer a minimally invasive surgery and only needs small incisions in the patients abdomen. Doctors can then insert a small camera and other medical instruments to target and destroy the tumor. Recent clinical trials have shown that laparoscopic surgery is equally effective as previous surgery but allows for a much easier recovery.
Other types of surgeries for renal cancer include:
- Robotic Partial Nephrectomy – In a partial nephrectomy, only the affected area of the kidney is removed.
- Minimally Invasive Urologic Surgery
- Radiofrequency Ablation – In Ablation surgeries, extreme temperatures are used to target and kill cancer cells. In radiofrequency ablation, a needle is inserted into the kidney tumour from the outside. The next step is to kill the cancer cells by sending an electrical current through them. Cryoablation and radiofrequency ablation are common alternatives to surgery that may help certain people.
- Cryoablation – Doctors puncture the skin, inject liquid nitrogen, and remove the tumour from the kidney. Cold gas is then used to freeze the cancer cells.
- Laparoscopic Radical Nephrectomy – During a radical nephrectomy, both kidneys and part of the tissue around them are surgically removed. Lymph nodes around the affected area could also be taken out. After the loss of a kidney, the goal is for the healthy kidney to take over the responsibilities of the failing one.
Active Surveillance – Small Kidney Tumors
For some patients, doctors carefully monitor the tumor for abnormal growth over time. This process is known as “watchful waiting.” Or “active surveillance”. The final decision to pursue a treatment action after active surveillance will depend on several factors, including:
- Patient age
- Patient overall health
- Size and location of tumor – Via imaging (CT, MRI)
- Overall growth rate of a tracked tumor over time
Immunotherapy Kidney Cancer in 2023
Biologic based therapies such as NK Cell Therapy also known as Immunotherapy, are a new type of kidney cancer treatment that is designed to increase our body’s own defense mechanisms to fight cancer. mRNA technology and Biologic therapies can use autologous materials (made by the patients body) or allogenic materials (cultured inside laboratory) to target, restore and boost the immune systems function. It can be used to:
- Containing the cancer from spreading to other areas in the body
- Slowing down or stopping the growth and development of existing cancer cells
- Helping our immune system function better and helping it destroy cancer cells
Stem Cell Treatment for Kidney Cancer
Most patients diagnosed with Renal cell carcinoma (RCC) are treated with combinations of radiation therapy, chemotherapy, or surgery. Radiation based therapies are disadvantageous as the high-energy particle rays do not target the cancer cells and destroy healthy cells causing severe side effects. The levels of radiation exposure in chemotherapeutic doses must be limited to avoid organ toxicity. Therefore, the 21st Century approach requires more precisely targeted therapies that are capable of killing cancer cells while ignoring the healthy cells.
The combination of modern immunological cancer therapies and MSC+ stem cells uses a more holistic approach and is significantly less toxic while maintaining similar and often better results depending on the type, age, and diagnosis stage. Immune boosting therapies are also more effective in achieving long-term tumor immunosurveillance while reducing the chance of relapse.
Its time to change how the world treats cancer
Immunological therapies for kidney cancer can increase long-term disease-free survival and are prescribed as adjuvant therapy for patients with low white blood cell counts. Stem cell therapy for renal cancer helps boost a patient immune system with a naturally produced growth factor to enhance the cancer-fighting capacity.
Immunotherapy for kidney cancer is quickly becoming a viable standard-of-care treatment and, in some cases, a complete cure. Immunotherapies refers to manipulating or mobilizing the patient’s immune system to treat or cure kidney cancer. Immunological therapies can also be performed via manipulation of genes using Dendritic cells (DCs), Immune modulators, monoclonal antibodies therapy, adoptive cell transfer and the new oncolytic virus therapy, which is a virus-based delivery system of modified genes where the payload uses the viruses as a host to carry past the patient’s immune system.
Modified CAR-T Cells for Kidney Cancer
Patients who are diagnosed with stage 3 kidney cancer who initially might have responded well to medications that target PD-1 protein (checkpoint inhibitors) can, over a short time, develop resistance to these therapies, significantly if cancer has metastasized from its primary location to spawn additional kidney lesion and tumors. In such cases, CAR T Cells & genes encoded with tumor-associated antigens (TAA) induces a much for an adequate response from the immune system.
Earlier clinical trials on late stage kidney cancer focused on identifying the proliferating progenitor cells (CD34+) in human blood. These progenitor cells are stimulated by cytokines (GM-CSF and TNF-alpha) to differentiate into dendritic cells rapidly. For some cases, using a combination of IL-4 & GM-CSF helps to generate significantly larger quantities of cancer-fighting dendritic cells from monocytes and macrophages.
Immunological therapy for kidney cancer might soon be the gold standard in the treatment of renal tumors for these reasons:
- Targeted Kidney cancer immunotherapy can target and debulk the tumor mass at the same time kill the tumor via inducing a normal cellular response and paracrine cell signaling
- The combination of stem cells and immunotherapy growth factors help to reduce nearby lesions and prevents metastases from forming on the cellular level, thus improving cytoreduction while avoiding the destruction of normal healthy cells
- Renal Cancer stem cells therapies are non-toxic and may not require the use of chemotherapy and its adverse side effects
- Immunological therapies help save a copy of the memory responses (immunosurveillance). This significantly reduced the risk of relapses.
- Recent research shows that adoptive T cell therapy is successful in the treatment of renal cancer. This breakthrough therapy for kidney cancer is essential as without having the treatment, the estimated five-year survival rate is just below 8%.
Renal Cancer: Alternative Treatments
The Regeneration Center offers an alternative treatment for kidney cancer that can treat or reverse symptoms depending on the patient’s stage. The best defense from any cancer is first being informed about the disease to make an informed decision about biological treatment for cancer using stem cells.
Stem Cell Therapy for Kidney Cancer
Our stem cell therapy for kidney cancer is customized specific to patient needs. The individualized protocol helps patients fight cancer using traditional cancer treatment and alternative natural cellular-based therapies. For over 15 years, our approach to integrated healthcare relies on research-based treatment plans comprehensive and specific to patient medical needs to ensure the highest chances of success. The Regeneration Center offer a holistic approach to modern healthcare. We strive to fight cancer and alleviate underlying symptoms that can increase the patient’s quality of life. Cancer stem cell treatment plans also helps patients achieve long term remission rates by addressing the root cause of disease and not just its symptoms.
Warning and Dangers of Cancer Herbal Therapies
Some herbal based treatment might help treat some symptoms associated with kidney cancer, however patients diagnosed with cancer need to be extra precautious before digesting an herbal remedy of unknown sources. A compromised renal system may have a much harder time metabolizing substances. Since many herbal preparations and extracts are alcohol-based, kidney cancer patients should always double-check all the ingredients before taking any herbs. Furthermore, some herbal supplements for kidney cancer can cause excessive bleeding and prevent blood from clotting properly.
Primary kidney cancer can be defeated. Our goal is to heal the body from the inside out and help patients achieve the longest possible rates of remission. Our natural cell based approach to healthcare means that we will work with you and your primary care doctor to determine the best overall treatment options. Our treatment evaluation for kidney cancer does require review of current medical records. Patients who for some reason are not responding to traditional treatments or those where surgery is not a good option, our team can review your Radiology scans (CT, ultrasound, or MRI) and lab tests to target the tumor(s) better and destroy them using minimally invasive techniques. We provide you with access to innovative kidney cancer treatment techniques and immunotherapies when appropriate. The Regeneration Center also offers its patients comprehensive follow-up care and survivorship programs ( In Thailand only) for patients recovering from kidney cancer.
The outlook for patients diagnosed with renal cancer has never been better. Thanks to modern medicine, many people survive the disease. The Regeneration Cancer center has cared for patients worldwide who were diagnosed with different types of kidney lesions and stages of kidney cancer. To learn more about our treatment protocols and biological therapy for kidney cancer please contact us today.
Published Clinical Citations
 ^ Linehan WM, Schmidt LS, Crooks DR, Wei D, Srinivasan R, Lang M, Ricketts CJ. The Metabolic Basis of Kidney Cancer. Cancer Discov. 2019 Aug;9(8):1006-1021. doi: 10.1158/2159-8290.CD-18-1354. Epub 2019 May 14. PMID: 31088840.
 ^Dziedzic K, Pleniceanu O, Dekel B. Kidney stem cells in development, regeneration and cancer. Semin Cell Dev Biol. 2014 Dec;36:57-65. doi: 10.1016/j.semcdb.2014.08.003. Epub 2014 Aug 13. PMID: 25128731.
 ^Bi LK, Zhou N, Liu C, Lu FD, Lin TX, Xuan XJ, Jiang C, Han JL, Huang H, Zhang CX, Dong W, Liu H, Huang J, Xu KW. Kidney cancer cells secrete IL-8 to activate Akt and promote migration of mesenchymal stem cells. Urol Oncol. 2014 Jul;32(5):607-12. doi: 10.1016/j.urolonc.2013.10.018. Epub 2014 Jan 10. PMID: 24412633.
 ^ Fang P, Zhou L, Lim LY, Fu H, Yuan ZX, Lin J. Targeting Strategies for Renal Cancer Stem Cell Therapy. Curr Pharm Des. 2020;26(17):1964-1978. doi: 10.2174/1381612826666200318153106. PMID: 32188377